Academic research in health care and pharmaceutical economics can provide insights relevant to antitrust and competition enforcers and practitioners. High-profile litigation may also motivate topics for academic research.
Focusing on the intersection of academic research and litigation matters, Daniel Shack and Annabelle Fowler highlight key research developments and discussion topics showcased at the 2025 Annual Conference of the American Society of Health Economists (ASHEcon), held in Nashville.
